CMS Biosimilars Guidance

CMS Biosimilars Guidance

Earlier this week the Centers for Medicare & Medicaid Services (CMS) issued four guidance documents detailing how Medicare Parts B and D as well as the Medicaid Drug Rebate Program will treat biosimilar therapies.

 Download CMS guidance documents.

Top